Creating a facility for large-scale production of biomaterials for infectious disease research
Official title: Biomaterial Manufacturing Suite in Support of NIH/NIAID and the Global Infectious Disease Research Community
Funded at American Type Culture Collection · NIH-10795293 · Data updated 2026-11-12
This study is creating a special facility to make important materials quickly for researchers studying infectious diseases, helping them work better on finding solutions for outbreaks that affect public health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | American Type Culture Collection NIH-funded |
| Lab location | 1 site (Manassas, United States) |
| Project start | September 6, 2023 |
| Project end | November 30, 2026 |
| Funding year | 2023 |
| Award (this year) | $4,798,286 |
| NIH project number | 1C06OD036014-01 |
| Project ID | NIH-10795293 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by infectious diseases or those at risk of epidemic outbreaks.
✕Less likely to help
Patients with non-infectious diseases or conditions unrelated to the pathogens being studied may not receive any benefit from this research.
What this research studies
This project aims to build a Biomaterial Manufacturing Suite (BMS) within a High Containment Facility to support the production of biomaterials for infectious diseases. The BMS will enable the rapid development and large-scale manufacturing of materials needed for research on priority pathogens, which are critical for public health. By providing well-characterized challenge materials at no cost, this facility will enhance the capabilities of researchers working on epidemic and pandemic threats. The project focuses on optimizing the growth and characterization of pathogenic organisms to facilitate better research outcomes.
Why it matters
Potential benefit: If successful, this research could significantly improve the availability of essential biomaterials for infectious disease research, leading to faster development of treatments and vaccines.
How similar studies have gone: Other research initiatives have successfully established similar facilities, indicating a proven approach to enhancing infectious disease research capabilities.
Where this research is happening
-
American Type Culture Collection
Manassas, United States Active
Researchers
- Principal investigator: Bradford, Rebecca — American Type Culture Collection
- Study coordinator: Bradford, Rebecca
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.